REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka N1G Barnaula AO (Аптека N1Г Барнаула АО) (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Apteka N1G Barnaula AO Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Apteka N1G Barnaula AO (Аптека N1Г Барнаула АО) is an enterprise in Russia, with the main office in Barnaul. The company operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on April 16, 2009. There was a net sales revenue increase of 14.5% reported in Apteka N1G Barnaula AO (Аптека N1Г Барнаула АО)’s latest financial highlights for 2024. There was a total growth of 13.73% in Apteka N1G Barnaula AO (Аптека N1Г Барнаула АО)’s total assets over the same period. The net profit margin of Apteka N1G Barnaula AO (Аптека N1Г Барнаула АО) increased by 0.72% in 2024.

Headquarters
Lenina, 28
Barnaul; Altai Krai; Postal Code: 656056

Contact Details: Purchase the Apteka N1G Barnaula AO (Аптека N1Г Барнаула АО) report to view the information.

Basic Information
Registered Capital:
Purchase the Apteka N1G Barnaula AO (Аптека N1Г Барнаула АО) report to view the information.
Financial Auditors:
Purchase the Apteka N1G Barnaula AO (Аптека N1Г Барнаула АО) report to view the information.
Incorporation Date:
April 16, 2009
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Apteka N1G Barnaula AO (Аптека N1Г Барнаула АО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
14.5%
Total operating revenue
14.5%
Operating profit (EBIT)
-40.05%
Net Profit (Loss) for the Period
8002.94%
Total Assets
13.73%
Total Equity
5.96%
Operating Profit Margin (ROS)
-0.64%
Net Profit Margin
0.72%
Return on Equity (ROE)
5.56%
Quick Ratio
0.06%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?